Raydiant Oximetry Completes Enrollment of First 15 Patients in IDE Pilot Study at LSU Health Shreveport
SAN RAMON, Calif., June 15, 2026 /PRNewswire/ -- Raydiant Oximetry, Inc., a clinical-stage medical device company pioneering innovations in fetal pulse oximetry through advanced biophotonics and machine learning, announced today the completion of enrollment and data collection for the first 15 patients in its Investigational Device Exemption (IDE) Pilot Study